Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer
Fadraciclib (CYC065) 是一种新型 CDK 抑制剂，靶向癌症中的关键促生存和致癌途径
期刊:PLoS One
影响因子:2.9
doi:10.1371/journal.pone.0234103
Sheelagh Frame, Chiara Saladino, Craig MacKay, Butrus Atrash, Peter Sheldrake, Edward McDonald, Paul A Clarke, Paul Workman, David Blake, Daniella Zheleva
